Deciphera Pharmaceuticals, Inc. General and Administrative Expense
Deciphera Pharmaceuticals, Inc. reported General and Administrative Expense of $68.12 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2020-03-09
- Deciphera Pharmaceuticals, Inc. general and administrative expense for the quarter ending 2019-12-31 was $23.74M, a 266.65% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. general and administrative expense for the quarter ending 2019-09-30 was $17.98M, a 241.87% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. general and administrative expense for the quarter ending 2019-06-30 was $13.16M, a 195.62% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. general and administrative expense for the quarter ending 2019-03-31 was $13.24M, a 163.35% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. general and administrative expense for fiscal 2019 was $68.12M, a 221.12% increase from fiscal 2018.
- Deciphera Pharmaceuticals, Inc. general and administrative expense for fiscal 2018 was $21.21M, a 85.73% increase from fiscal 2017.
- Deciphera Pharmaceuticals, Inc. general and administrative expense for fiscal 2017 was $11.42M, a 101.25% increase from fiscal 2016.
- Deciphera Pharmaceuticals, Inc. general and administrative expense for fiscal 2016 was $5.67M, a 10.52% increase from fiscal 2015.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $23.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $41.72M derived: sum of 2 quarters · filed 2020-03-09 | $54.88M derived: sum of 3 quarters · filed 2020-03-09 | $68.12M 10-K · filed 2020-03-09 |
| 2019-09-30 | $17.98M 10-Q · filed 2019-11-04 | $31.14M derived: sum of 2 quarters · filed 2019-11-04 | $44.38M 10-Q · filed 2019-11-04 | $50.85M derived: sum of 4 quarters · filed 2020-03-09 |
| 2019-06-30 | $13.16M 10-Q · filed 2019-08-02 | $26.40M 10-Q · filed 2019-08-02 | $32.87M derived: sum of 3 quarters · filed 2020-03-09 | $38.13M derived: sum of 4 quarters · filed 2020-03-09 |
| 2019-03-31 | $13.24M 10-Q · filed 2019-05-09 | $19.71M derived: sum of 2 quarters · filed 2020-03-09 | $24.97M derived: sum of 3 quarters · filed 2020-03-09 | $29.42M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-12-31 | $6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $11.73M derived: sum of 2 quarters · filed 2020-03-09 | $16.19M derived: sum of 3 quarters · filed 2020-03-09 | $21.21M 10-K · filed 2020-03-09 |
| 2018-09-30 | $5.26M 10-Q · filed 2019-11-04 | $9.71M derived: sum of 2 quarters · filed 2019-11-04 | $14.74M 10-Q · filed 2019-11-04 | $19.42M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | $4.45M 10-Q · filed 2019-08-02 | $9.48M 10-Q · filed 2019-08-02 | $14.16M derived: sum of 3 quarters · filed 2020-03-09 | $16.59M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | $5.03M 10-Q · filed 2019-05-09 | $9.71M derived: sum of 2 quarters · filed 2020-03-09 | $12.14M derived: sum of 3 quarters · filed 2020-03-09 | $14.38M derived: sum of 4 quarters · filed 2020-03-09 |
| 2017-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $7.11M derived: sum of 2 quarters · filed 2020-03-09 | $9.35M derived: sum of 3 quarters · filed 2020-03-09 | $11.42M 10-K · filed 2020-03-09 |
| 2017-09-30 | $2.43M 10-Q · filed 2018-11-08 | $4.67M derived: sum of 2 quarters · filed 2018-11-08 | $6.74M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $2.24M 10-Q · filed 2018-08-07 | $4.31M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $2.07M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $5.67M 10-K · filed 2019-03-14 | |||
| 2015-12-31 | $5.13M 10-K · filed 2018-03-28 |